SHL joins Partnership Opportunities in Drug Delivery

Wednesday, September 25, 2019 by SHL

SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) conference from 7-8 October in Boston.

The company's debut exhibit will feature a vast array of products that provide solutions for the growing demands in self-injection treatments. Displays include Needle Isolation Technology (NIT®) - a pre-attached needle mechanism for cartridge-based auto-injectors that eliminates the need for users to manually attach the needle or directly contact with the needle upon injection preparation; the refined Molly® variation - an auto-injector family that offers devices for drug fill volumes up to 2.25mL and is designed to be mass-produced effectively and efficiently.

Owning 30 years of experience and industry knowledge, SHL continues to thrive in the self-injection treatment space, offering pharma companies a broad scope of services that include the design, development, and manufacturing of advanced drug delivery systems.

Visit SHL at Booth 24 at the Renaissance Boston Waterfront Hotel.


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.